Elevated body mass index predicts for longer overall survival duration in men with metastatic hormone-refractory prostate cancer
- PMID: 15800342
- DOI: 10.1200/JCO.2005.05.890
Elevated body mass index predicts for longer overall survival duration in men with metastatic hormone-refractory prostate cancer
Comment on
-
Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy.J Clin Oncol. 2004 Feb 1;22(3):439-45. doi: 10.1200/JCO.2004.03.132. Epub 2003 Dec 22. J Clin Oncol. 2004. PMID: 14691120
-
Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group.J Clin Oncol. 2004 Feb 1;22(3):446-53. doi: 10.1200/JCO.2004.04.181. Epub 2003 Dec 22. J Clin Oncol. 2004. PMID: 14691122
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical